Stereotactic fibrinolysis of spontaneous intracerebral hematoma using infusion of recombinant tissue plasminogen activator

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 2 B, 2002, Pages 362-366

  Nasser, José Augusto ^a,b,c   Falavigna, Asdrubal ^a   Bezerra, Márcio ^a,b   Martinez, Victor ^a,b   Freitas, Gabriel ^a,b   Alaminos, Armando ^a   Bonatelli, Antônio ^b   Ferraz, Fernando ^b  

^a ESTÁCIO DE SÁ UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c EPM UNIFESP ^*  (Brazil)

Author keywords

Hematoma lysis; Recombinant tissue plasminogen activator; Spontaneous intracerebral hematoma; Stereotaxy

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BASAL GANGLION HEMORRHAGE; BRAIN HEMATOMA; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYSIS; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; INTRACRANIAL PRESSURE; MALE; MINIMALLY INVASIVE SURGERY; PROSPECTIVE STUDY; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE;

EID: 0036306673     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2002000300004     Document Type: Article

References (20)

1. Schwarz S, Jauss M, Krieger D, Dorfler A, Albert F, Hacke W. Haematoma evacuation does not improve outcome in spontaneous supratentorial intracerebral hemorrhage: a case-control study. Acta Neurochir (Wien) 1997;139:897-904.
2. Backlund E, van Hoslt M. Controlled subtotal evacuation of intracerebral hematomas by stereotactic technique. Surg Neurol 1978;9:99-101.
3. Higgins AC, Nashold BS. Stereotactic evacuation of large intracerebral haematomas. Appl Neurophysiol 1980;43:96-103.
4. Doi E, Moriwaki M, Komai N, Iwamoto M. Stereotactic evacuation of intracerebral hematomas. Neurol Med Chir (Tokyo) 1982;22:461-467.
5. Mohadjer M, Braus DF, Myers A, Scheremet R, Krauss JK. CT-stereotactic fibrinolysis of spontaneous intracerebral hematomas. Neurosurg Rev 1992;15:105-110.
6. Schaller C, Rohde V, Meyer B, Hassler W. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 1995;36:328-335.
7. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975;1:480-484.
8. Deinsberger W, Vogel J, Fuchs C, Auer LM, Kuschinsky W, Boker DK. Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats. Neurol Res 1999;21:517-523.
9. Grabb PA. Traumatic intraventricular hemorrhage treated with intraventricular recombinant -tissue plasminogen activator: technical case report. Neurosurgery 1998;43:966-969.
10. Kim MH, Kim LY, Song JH, Shin KM. Surgical options of hypertensive intracerebral hematoma: stereotactic endoscopie removal versus stereotactic catheter drainage. J Korean Med Sci 1998;13:533-540.
11. Lippitz BL, Mayfrank L, Spetzger U, Warnke JP, Bertalanffy H, Gilsbach JM. Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 1994;127:157-160.
12. Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular hemorrhage. Acta Neurochir (Wien) 1993;122:32-38.
13. Chung CS, Caplan LR, Han W, Pessin MS, Lee KH, Kim JM. Thalamic hemorrhage. Brain 1996;119:1873-1886.
14. Thurim S, Horowitz D, Sacher M, Godbold J. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Critical Care Med 1999;27:617-621.
15. Amano K, Kawamura H, Tanikawa T, et al.. Surgical treatment of hypertensive intracerebral haematoma by CT-guided stereotactic surgery. Acta Neurochir (Wien) 1987;39(Suppl):41-44.
16. Masuda T, Dorhmann GJ, Kwaan HC, Erickson RK, Wollman RL. Fibrinolytic activity in experimental intracerebral hematoma. J Neurosurg 1988;68:274-278.
17. Yague L, Garcia-March G, Paniagua C, et al. Stereotactic evacuation and local administration in intracerebral haematomas: a comparative study. Acta Neurochir (Wien) 1987;39(Suppl):45-48.
18. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N. Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus. Ach Dis Child Fetal Neonatal 1996;75:20-26.
19. Altumbabic M, Peeling J, Del Biggio MR. Intracerebral hemorrhage in the rat: effects of hematoma aspiration. Stroke 1998;29:1917-1922.
20. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke 1999;30:1167-1173.